Amro Elrefaei MD 🧠

Neurology Endovascular Surgery Fellow. U of Iowa. EGYPT 🇪🇬 USA 🇺🇸

[Malik Ghannam @GhannamMalik]

Endovascular Treatment of Medium-Vessel-Occlusion Strokes | New England Journal of Medicine https://t.co/LNeizZfY6a

[Amro Elrefaei MD 🧠 @AmroElrefaeiMD]

👏🏼👏🏼👏🏼Great results!!

[Amrou Sarraj @amrsarrajMD]

On behalf of the large core trials principal investigators, immensely proud and honored to present primary results of the ATLAS IPD meta-analysis @ESOstroke with simultaneous publication in

@TheLancet -https://t.co/uY3DlB6KPJ

EVT not only improved outcomes compared to medical care, but functional independence and independent ambulation were also achieved in a meaningful proportion of patients. Additionally, EVT was life-saving, as one of the few reperfusion therapies to achieve it. With the exception of patients with very large core (volume ≥150 ml) in the late time window, where evidence is limited because of wide confidence intervals but benefit could not be excluded, EVT demonstrated consistent benefit regardless of ASPECTS and ischaemic core strata.

Our deepest gratitude to the patients, their families, and all investigators and coordinators at the trial sites. A mammoth collective effort over 3 years from 6 trials with practice changing results that improve care for 20% LVOs! #stroke #EVT #largecore #NoLVOleftbehind @XiaochuanHuo @VCostalat @oozaidat @VYogendrakumar @deeppujara @dliebesk @ARazzakMD @NguyenThanhMD @samialkasab @AmeerEHassan @Michael3Abraham @FelixSun1230 @HiroshiYamagam2 @SunilAShethMD @Fie0815 @RaulNogueiraMD @rgrandhi @PascalJabbourMD @shazamhussain @dr_mchen @mihill68 @lapergue6 @TudorGJovin @AlbertJYoo

[Amro Elrefaei MD 🧠 @AmroElrefaeiMD]

Published in Stroke (AHA Journal).
Evidence guiding blood pressure management after EVT.
🔗 https://t.co/uBXQDhhpMS.

#Stroke #VascularNeurology #NeuroTwitter #SVIN

[Amro Elrefaei MD 🧠 @AmroElrefaeiMD]

BE-FAST in Arabic

[Mission Thrombectomy @MThrombectomy]

BEFAST version in Arabic !
Brilliant acronym created by medical Student from Jordan!
#StrokeAdvocate

[Amro Elrefaei MD 🧠 @AmroElrefaeiMD]

Amazing work 👏🏻👏🏻my great mentor Dr. Sarraj. @amrsarrajMD

[World Stroke Academy @WorldStrokeEd]

🔥ATLAS 🧠large core stroke

✅EVT benefit in early and late window
✅EVT benefit ASPECT 0-2 and 3-5
🔴 EVT not benefit ASPECT 0-2 late window
✅ EVT benefit up to core 149 ml in early and late window

[Amro Elrefaei MD 🧠 @AmroElrefaeiMD]

Always happy and honored to participate with my friends and great current and future leaders 👏🏼👏🏼👏🏼

[Mohamed Elfil, MD @MohamedElfilMD]

Excited to share our new publication on Adjunctive MMAE for cSDH, pooling the latest trial data into robust evidence!
@almuftifawaz @hazemghaithMS @mashad_ahmad @AmroElrefaeiMD @zaiddnajdawi @stephanamayer
https://t.co/AcHDGQ21DM

[Amro Elrefaei MD 🧠 @AmroElrefaeiMD]

Check our latest publication "Adjunctive middle meningeal artery embolization for chronic subdural hematoma: A systematic review and meta-analysis of clinical trials" 🧠🧠

[Hazem Ghaith, MD @hazemghaithMS]

Check our publication, “Adjunctive middle meningeal artery embolization for chronic subdural hematoma: A systematic review and meta-analysis of clinical trials”.

@almuftifawaz @stephanamayer @MohamedElfilMD @mashad_ahmad @zaiddnajdawi @AmroElrefaeiMD

https://t.co/YQaO0tzOBk

[Amro Elrefaei MD 🧠 @AmroElrefaeiMD]

@MohamedElfilMD 👏🏼👏🏼👏🏼👏🏼👏🏼👏🏼

[Amro Elrefaei MD 🧠 @AmroElrefaeiMD]

Very honored and excited to participate with the whole team! 🧠🧠🧠🇪🇬

[Mohamed Elfil, MD @MohamedElfilMD]

Very proud and excited to virtually participate in the MENA-Vascular and Interventional Neurology Master Class 🇪🇬🧠

[Amro Elrefaei MD 🧠 @AmroElrefaeiMD]

@MohamedElfilMD @almuftifawaz @mashad_ahmad @hazemghaithMS @zaiddnajdawi @Dr_Aladawi @kaurgurmeen Congratulations 👏🏼 👌🏼

[Amro Elrefaei MD 🧠 @AmroElrefaeiMD]

Amazing work 👏🏼👏🏼👏🏼

[Mohamed Elfil, MD @MohamedElfilMD]

Check our publication, "Transradial versus transfemoral access in middle meningeal artery embolization for chronic subdural hematoma: A systematic review and meta-analysis".
https://t.co/rm8fkonVhw
@almuftifawaz @mashad_ahmad @hazemghaithMS @zaiddnajdawi @Dr_Aladawi @kaurgurmeen

[Amro Elrefaei MD 🧠 @AmroElrefaeiMD]

Congratulations 👏🏼👏🏼

[Amrou Sarraj @amrsarrajMD]

Congratulations @CerebrovascLab @AaronCalienes on leading this important analysis to shed light on management of extracranial ICA occlusion sub population.

[Amro Elrefaei MD 🧠 @AmroElrefaeiMD]

Congratulations Dr. @wbrinjikji 👏🏼👏🏼

[SVIN @svinsociety]

Congratulations to Dr. Waleed Brinjikji @wbrinjikji, recipient of the SVIN 2024 Innovation Award for his pioneering work on CSF venous fistula, among other achievements.

We were delighted to honor him at the #SVIN24 gala with Dr. Nasr at the San Diego Zoo.

[Amro Elrefaei MD 🧠 @AmroElrefaeiMD]

Exciting times ahead! Congratulations to Dr. Sarraj, @amrsarrajMD, for leading the way with the SELECT LATE trial. A new era in stroke care is on the horizon!

[Amrou Sarraj @amrsarrajMD]

Honored and grateful for the opportunity to assess the role of Endovascular Thrombectomy beyond 24 hours of last known well through SELECT LATE international, multicenter pragmatic clinical trial - https://t.co/KVlRMz0HRK funded by @PCORI @UHhospitals

Excited to collaborate with my Co-Investigators Bruce Campbell @UniMelb, Jeff Saver @UCLANeurology, Jim Grotta @memorialhermann, @NguyenThanhMD @The_BMC, @StavTjoumakaris @TJUHNeurosurg, Steve Messe @PennNeurology, Leonid Churilov @UniMelb and Clark Sitton @McGovernMed for the successful conduct of the trial.

Grateful to our stakeholders @MitchElkind, @AmeerEHassan, @dr_mchen, Erin Supan, Eric Hess, Daniel Ellenberger and patients’ advocates Christina Globuski, Matthew and Laura Antenucci, James and Jessica Sulecki and Kelly Montgomery for their guidance on how to make our study more pragmatic and patient-centered.

[Amro Elrefaei MD 🧠 @AmroElrefaeiMD]

The future of vascular and interventional neurology 👏🏼👏🏼 amazing work @hazemghaithMS @MohamedElfilMD

[Hazem Ghaith, MD @hazemghaithMS]

📢 Clinical Policy/Guidelines citation!

Glad to see our paper about IVT + MT for AIS-LVO cited in the clinical policy/guidelines of the American College of Emergency Medicine Physicians (ACEP).

https://t.co/7mAbUtWHCb

@MohamedElfilMD, @NegidaMD, @KhaledHamam26

[Mohammad El-Ghanem @elghanemmoh]

Great summary of the presented Trials at @svinsociety annual meeting! #SVIN24
@NguyenThanhMD
@almuftifawaz
@AshuPJadhav
@YoungNIR
@ShadiYaghi2
@WomenInNeuroIR
@StrokeAHA_ASA
@AANmember
@SNISinfo

[Amro Elrefaei MD 🧠 @AmroElrefaeiMD]

We're fortunate to live in an era where technology empowers us to be more efficient, innovative, and impactful-saving lives and improving outcomes everyday 🙌🏼.
Excited to share our publication.
@OmarAlJanabiMD @SheriefGhozy @WBrinjikji
#stroke #AI https://t.co/0YRIb4tJl9

[Amro Elrefaei MD 🧠 @AmroElrefaeiMD]

Congratulations @samialkasab! Great work 👏🏼

[Ali A. Alsarah @AlshaikhlyAli]

Congratulations to Dr @samialkasab for leading this great work. Thanks for my amazing mentor Dr Regenhardt @rwregen
For giving me the chance to participate in this great project.

RESCUE ICAS

https://t.co/oovlW3ZPWs

[Amro Elrefaei MD 🧠 @AmroElrefaeiMD]

@OmarAlJanabiMD is one of the most active people and hos vision will serve the whole Vascular Neurology community. Vote for him 🙏🏻

[عُمَرْ ألجَنْابِي Omar Al-Janabi MD, MS, PhD @OmarAlJanabiMD]

Do not forget to cast your vote by 11-27-2024 using the following link
https://t.co/BjmASZHmyJ

You have to be an AAN member to be able to vote.

Lets go vascular neurology community!